CDH1 and nasopharyngeal carcinoma: In contrast, the staining intensity of E-cadherin was greatly reduced in BM1-BART9 tumors (Figure 5F), suggesting that miR-BART9 also reduces E-cadherin levels in NPC tumors in vivo.